Plain-English translation of NCT06272864 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →The BEGIN Study is testing a new genetic analysis tool called the BostonGene Tumor Portrait test that examines your cancer cells in detail to identify treatment options that may work best for you. This test looks at genetic and molecular changes in your tumor and the immune cells around it. The study wants to see how useful this test is in real-world cancer clinics and whether it helps doctors choose more effective treatments.
Cancer treatment has advanced significantly, with doctors now able to use targeted therapies and immune-based treatments tailored to specific genetic changes in each patient's tumor. However, many cancer patients don't get comprehensive genetic testing, so doctors may miss opportunities to match patients with the best available treatments. This study aims to show whether using this genetic testing tool in community clinics can help more patients find treatments that are right for their specific cancer.
You likely qualify if…
You likely don't qualify if…
If you enroll, doctors will collect information about your medical history and current treatment. Your cancer tissue will be sent for comprehensive genetic analysis using the BostonGene Tumor Portrait test, which typically takes 1–2 weeks to complete. The study team will track your treatment decisions and outcomes over approximately two years, collecting information about which treatments you receive and how they work. You'll be participating at a community cancer clinic near you, not a research hospital.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States